Compare GRDX & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRDX | CURX |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 7.6M |
| IPO Year | N/A | 2025 |
| Metric | GRDX | CURX |
|---|---|---|
| Price | $2.44 | $0.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 142.7K | ★ 5.7M |
| Earning Date | 01-01-0001 | 09-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.92 | $0.26 |
| 52 Week High | $5.30 | $9.18 |
| Indicator | GRDX | CURX |
|---|---|---|
| Relative Strength Index (RSI) | 41.96 | 66.66 |
| Support Level | $2.03 | $0.37 |
| Resistance Level | $3.41 | $0.51 |
| Average True Range (ATR) | 0.37 | 0.05 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 26.67 | 42.20 |
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.